UPDATE: Goldman Sachs Downgrades Taysha Gene Therapies (TSHA) to Neutral
Tweet Send to a Friend
(Updated - November 9, 2022 6:24 AM EST)
Goldman Sachs analyst Salveen Richter downgraded Taysha Gene Therapies (NASDAQ: TSHA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter downgraded Taysha Gene Therapies (NASDAQ: TSHA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
